[1]
“THE ROLE OF DYSHORMONAL DISORDERS OF LEPTIN AND GHRELIN IN THE DEVELOPMENT OF DYSLIPIDEMIA AND METABOLIC SYNDROME”, MAJMHS, vol. 2, no. 3, pp. 7–16, Mar. 2026, Accessed: Apr. 21, 2026. [Online]. Available: https://usajournals.org/index.php/1/article/view/2051